Work

Updated Results of Phase II Study of Cyclophosphamide(Cy), Bortezomib(Bz), Pegylated Doxorubicin(DOX), and Dexamethasone(dex), (CVDD), in Patients with Newly Diagnosed Myeloma:an Effective Induction Regimen for High Risk Disease

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.4071.4071

Authors: Melissa Alsina, Rachid Baz, Kenneth H. Shain, Leonel Ochoa, Taiga Nishihori, Daniel M Sullivan, Binglin Yue, Jongphil Kim, William Dalton

Institution: Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551420953

FWCI: 0.635

Cites:

Cited by: 4

Related to: 10